1. Home
  2. QLGN vs SGBX Comparison

QLGN vs SGBX Comparison

Compare QLGN & SGBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • SGBX
  • Stock Information
  • Founded
  • QLGN 1996
  • SGBX 2007
  • Country
  • QLGN United States
  • SGBX United States
  • Employees
  • QLGN N/A
  • SGBX N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • SGBX RETAIL: Building Materials
  • Sector
  • QLGN Health Care
  • SGBX Consumer Discretionary
  • Exchange
  • QLGN Nasdaq
  • SGBX Nasdaq
  • Market Cap
  • QLGN 2.8M
  • SGBX 2.7M
  • IPO Year
  • QLGN N/A
  • SGBX 2017
  • Fundamental
  • Price
  • QLGN $3.16
  • SGBX $0.65
  • Analyst Decision
  • QLGN
  • SGBX
  • Analyst Count
  • QLGN 0
  • SGBX 0
  • Target Price
  • QLGN N/A
  • SGBX N/A
  • AVG Volume (30 Days)
  • QLGN 10.7K
  • SGBX 1.1M
  • Earning Date
  • QLGN 08-13-2025
  • SGBX 08-13-2025
  • Dividend Yield
  • QLGN N/A
  • SGBX N/A
  • EPS Growth
  • QLGN N/A
  • SGBX N/A
  • EPS
  • QLGN N/A
  • SGBX N/A
  • Revenue
  • QLGN N/A
  • SGBX $4,574,857.00
  • Revenue This Year
  • QLGN N/A
  • SGBX $1,628.82
  • Revenue Next Year
  • QLGN N/A
  • SGBX N/A
  • P/E Ratio
  • QLGN N/A
  • SGBX N/A
  • Revenue Growth
  • QLGN N/A
  • SGBX N/A
  • 52 Week Low
  • QLGN $2.85
  • SGBX $0.30
  • 52 Week High
  • QLGN $29.44
  • SGBX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 32.55
  • SGBX 45.80
  • Support Level
  • QLGN $3.37
  • SGBX $0.60
  • Resistance Level
  • QLGN $3.70
  • SGBX $0.68
  • Average True Range (ATR)
  • QLGN 0.21
  • SGBX 0.11
  • MACD
  • QLGN -0.05
  • SGBX -0.02
  • Stochastic Oscillator
  • QLGN 0.00
  • SGBX 20.71

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

Share on Social Networks: